Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 62% ± 24% | |
GABAergic neuron | 8 studies | 41% ± 15% | |
neuron | 6 studies | 31% ± 12% | |
interneuron | 6 studies | 44% ± 14% | |
amacrine cell | 5 studies | 40% ± 14% | |
granule cell | 4 studies | 47% ± 13% | |
GABAergic interneuron | 3 studies | 35% ± 13% | |
GABAergic amacrine cell | 3 studies | 47% ± 4% | |
glycinergic amacrine cell | 3 studies | 28% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 37% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 86% | 1092.17 | 2266 / 2642 | 51% | 3.67 | 358 / 705 |
adrenal gland | 2% | 4.06 | 5 / 258 | 24% | 2.38 | 56 / 230 |
ovary | 1% | 0.86 | 1 / 180 | 22% | 1.79 | 95 / 430 |
intestine | 13% | 22.75 | 124 / 966 | 1% | 0.02 | 4 / 527 |
skin | 0% | 0.11 | 1 / 1809 | 13% | 2.39 | 62 / 472 |
thymus | 1% | 1.08 | 5 / 653 | 6% | 0.56 | 35 / 605 |
uterus | 0% | 0 | 0 / 170 | 4% | 0.37 | 20 / 459 |
liver | 0% | 0 | 0 / 226 | 4% | 0.12 | 16 / 406 |
breast | 0% | 0 | 0 / 459 | 4% | 1.22 | 40 / 1118 |
esophagus | 1% | 1.11 | 11 / 1445 | 2% | 0.40 | 4 / 183 |
stomach | 2% | 2.50 | 6 / 359 | 1% | 0.03 | 3 / 286 |
lung | 0% | 0 | 0 / 578 | 3% | 0.16 | 29 / 1155 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.41 | 12 / 504 |
blood vessel | 2% | 3.66 | 28 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.17 | 1 / 178 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 2 / 901 |
peripheral blood | 0% | 0.18 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0042462 | Biological process | eye photoreceptor cell development |
GO_0005615 | Cellular component | extracellular space |
GO_0045202 | Cellular component | synapse |
GO_0032281 | Cellular component | AMPA glutamate receptor complex |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005515 | Molecular function | protein binding |
Gene name | OLFM3 |
Protein name | NOELIN3_V2 (Olfactomedin 3, isoform CRA_a) (cDNA FLJ52769, highly similar to Noelin-3) Noelin-3 (Olfactomedin-3) (Optimedin) |
Synonyms | UNQ1924/PRO4399 NOE3 hCG_33056 |
Description | |
Accessions | Q96PB7 ENST00000370103.9 [Q96PB7-3] ENST00000536598.1 [Q96PB7-6] ENST00000338858.9 [Q96PB7-1] Q6IMJ0 |